03/17/2021
https://www.congress.gov...
"I would agree with you completely."
"I think that might be something that you could help us with particularly those who design trials."
"We do not want to tell the F.D.A. how to do their job."
"I think that would be very important to give regulators those tools to say, 'You have explored this.'"